Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
No More Generics? Implications Of The US Pricing Bill
Aug 01 2022
•
By
Michael McCaughan
Will industry pivot away from small molecule drugs in the wake of new drug pricing legislation? • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Legislation
More from Pink Sheet